PHYTOpharmaceuticals Inc., a subsidiary of ESCAgenetics Corp.(AMEX:ESN), and Sun Hill Glucose Co. Ltd. have finalized theiragreement to collaborate in the production of taxol, an anti-cancerdrug.An agreement in principle was first announced April 20.Under the agreement, PHYTOpharmaceuticals, of San Carlos, Calif.,will assist Sun Hill, a Korean subsidiary of Sam Yang Group of Seoul,South Korea, to scale up its manufacturing process for the productionof taxol, using PHYTOpharmaceuticals plant cell fermentationtechnology. The scale-up process is expected to be completed by May1995. Sun Hill will then proceed to commercial production of taxol. _Philippa Maister

(c) 1997 American Health Consultants. All rights reserved.